Nakao, S., Uemichi, Y., Nagano, S., Mabuchi, M., Ohmori, S., Enomoto, D., . . . Shimizu, T. (2026). Effect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma. PLoS ONE, 21(3), 1. https://doi.org/10.1371/journal.pone.0338895
Chicago Style (17th ed.) CitationNakao, Shuhei, Yuki Uemichi, Shuji Nagano, Miyuki Mabuchi, Shiho Ohmori, Daichi Enomoto, Takehiko Ueyama, and Tadashi Shimizu. "Effect of Anticancer Activity of Aripiprazole Main Metabolite OPC-14857 on Malignant Glioblastoma." PLoS ONE 21, no. 3 (2026): 1. https://doi.org/10.1371/journal.pone.0338895.
MLA (9th ed.) CitationNakao, Shuhei, et al. "Effect of Anticancer Activity of Aripiprazole Main Metabolite OPC-14857 on Malignant Glioblastoma." PLoS ONE, vol. 21, no. 3, 2026, p. 1, https://doi.org/10.1371/journal.pone.0338895.